BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kermanizadeh A, Powell LG, Stone V, Møller P. Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape. Int J Nanomedicine 2018;13:7575-605. [PMID: 30510419 DOI: 10.2147/IJN.S177418] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Razzaq A, Qureshi IZ. Naproxen sodium nanoparticles are less toxic and gastroprotective agents than the conventional NSAID drug naproxen sodium in Balb/c mice. Toxicol Appl Pharmacol 2022;452:116192. [PMID: 35952772 DOI: 10.1016/j.taap.2022.116192] [Reference Citation Analysis]
2 Verma S, Kumar Tonk R, Albratty M, Ahmad Alhazmi H, Najmi A, Kumar R, Kumar M, Taleuzzaman M, Swami G, Shamsher Alam M. Design and evaluation of sustained release mucoadhesive film of sumatriptan succinate containing grafted co-polymer as the platform. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.07.014] [Reference Citation Analysis]
3 Banche-Niclot F, Licini C, Montalbano G, Fiorilli S, Mattioli-Belmonte M, Vitale-Brovarone C. 3D Printed Scaffold Based on Type I Collagen/PLGA_TGF-β1 Nanoparticles Mimicking the Growth Factor Footprint of Human Bone Tissue. Polymers (Basel) 2022;14:857. [PMID: 35267680 DOI: 10.3390/polym14050857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Malik S, Prasad S, Dhasmana A. Advancements in novel drug delivery systems: Providing a challenge and threat to oxidative stress in various diseases. Novel Therapeutic Approaches Targeting Oxidative Stress 2022. [DOI: 10.1016/b978-0-323-90905-1.00011-0] [Reference Citation Analysis]
5 Kermanizadeh A, Roberts G. Nanomaterial-Induced Extra-Pulmonary Health Effects – the Importance of Next Generation Physiologically Relevant In Vitro Test Systems for the Future of Nanotoxicology. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/978-3-030-88071-2_11] [Reference Citation Analysis]
6 Mustfa SA, Maurizi E, Mcgrath J, Chiappini C. Nanomedicine Approaches to Negotiate Local Biobarriers for Topical Drug Delivery. Adv Therap 2021;4:2000160. [DOI: 10.1002/adtp.202000160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 de Oliveira ALB, Cavalcante FTT, da Silva Moreira K, Lima PJM, de Castro Monteiro RR, Pinheiro BB, dos Santos KP, dos Santos JCS. Chitosan Nanoparticle: Alternative for Sustainable Agriculture. Nanomaterials and Nanotechnology 2021. [DOI: 10.1007/978-981-33-6056-3_4] [Reference Citation Analysis]
8 Kermanizadeh A, Cassee FR, de Jong W. The Potential Adverse Effects of Engineered Nanomaterial Exposure to Human Health Following Pulmonary, Oral and Dermal Exposure. Nanotoxicology in Humans and the Environment 2021. [DOI: 10.1007/978-3-030-79808-6_2] [Reference Citation Analysis]
9 Cottura N, Howarth A, Rajoli RKR, Siccardi M. The Current Landscape of Novel Formulations and the Role of Mathematical Modeling in Their Development. J Clin Pharmacol 2020;60 Suppl 1:S77-97. [PMID: 33205431 DOI: 10.1002/jcph.1715] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Chen J, Huang J. Sorafenib delivered by cancer cell membrane remodels tumor microenvironment to enhances the immunotherapy of mitoxantrone in breast cancer. J Mater Res 2020;35:3296-303. [DOI: 10.1557/jmr.2020.321] [Reference Citation Analysis]
11 Staroń A, Długosz O, Pulit-Prociak J, Banach M. Analysis of the Exposure of Organisms to the Action of Nanomaterials. Materials (Basel) 2020;13:E349. [PMID: 31940903 DOI: 10.3390/ma13020349] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
12 Vaiserman A, Koliada A, Zayachkivska A, Lushchak O. Nanodelivery of Natural Antioxidants: An Anti-aging Perspective. Front Bioeng Biotechnol 2019;7:447. [PMID: 31998711 DOI: 10.3389/fbioe.2019.00447] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 32.5] [Reference Citation Analysis]
13 Das S, Das MK, Deka T, Singha LR, Das P. Nanomedicines and Nanodrug Delivery Systems: Trends and Perspectives. Nano Medicine and Nano Safety 2020. [DOI: 10.1007/978-981-15-6255-6_6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Bueno J. ADMETox: Bringing Nanotechnology Closer to Lipinski’s Rule of Five. Nanotechnology in the Life Sciences 2020. [DOI: 10.1007/978-3-030-43855-5_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Seremeta KP, Sosnik A. Delivery platforms for oral drug administration. Nanotechnology for Oral Drug Delivery 2020. [DOI: 10.1016/b978-0-12-818038-9.00010-7] [Reference Citation Analysis]
16 Kermanizadeh A, Berthing T, Guzniczak E, Wheeldon M, Whyte G, Vogel U, Moritz W, Stone V. Assessment of nanomaterial-induced hepatotoxicity using a 3D human primary multi-cellular microtissue exposed repeatedly over 21 days - the suitability of the in vitro system as an in vivo surrogate. Part Fibre Toxicol 2019;16:42. [PMID: 31739797 DOI: 10.1186/s12989-019-0326-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
17 Lushchak O, Strilbytska O, Koliada A, Zayachkivska A, Burdyliuk N, Yurkevych I, Storey KB, Vaiserman A. Nanodelivery of phytobioactive compounds for treating aging-associated disorders. Geroscience 2020;42:117-39. [PMID: 31686375 DOI: 10.1007/s11357-019-00116-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
18 Kayraklioglu N, Horuluoglu B, Elango M, Klinman DM. Critical Role of B Cells in Toll-Like Receptor 7-Mediated Protection against Listeria monocytogenes Infection. Infect Immun 2019;87:e00742-19. [PMID: 31591164 DOI: 10.1128/IAI.00742-19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
19 Kermanizadeh A, Brown DM, Moritz W, Stone V. The importance of inter-individual Kupffer cell variability in the governance of hepatic toxicity in a 3D primary human liver microtissue model. Sci Rep 2019;9:7295. [PMID: 31086251 DOI: 10.1038/s41598-019-43870-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
20 Ghosh S, Ghosh S, Sil PC. Role of nanostructures in improvising oral medicine. Toxicol Rep 2019;6:358-68. [PMID: 31080743 DOI: 10.1016/j.toxrep.2019.04.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
21 Cappellano G, Comi C, Chiocchetti A, Dianzani U. Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease. Int J Mol Sci 2019;20:E204. [PMID: 30626016 DOI: 10.3390/ijms20010204] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 17.7] [Reference Citation Analysis]